Literature DB >> 7590817

Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models.

N M Parish1, P R Hutchings, L O'Reilly, R Quartey-Papafio, D Healey, P Ozegbe, A Cooke.   

Abstract

This chapter aims to describe ways in which autoimmunity can be prevented or reversed and 'self-tolerance' re-established. To this end we have largely restricted our overview to the two main autoimmune disease models with which we are involved, i.e. IDDM in NOD mice and EAT in H-2k mice although, where appropriate and to demonstrate a particular point, other models are mentioned. The chapter has been divided into sections covering protection afforded by 1) transgenes, 2) autoantigen and 3) by reagents targetting T-cell surface molecules. Where established, the mechanism by which protection or tolerance is achieved is described but where, as in most cases, it is unknown the possibilities are discussed. Investigations using T-cell lines and clones and on islet regeneration which are currently being followed as part of a comprehensive approach to the study of autoimmunity are included as separate sections and their relevance discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7590817     DOI: 10.1111/j.1600-065x.1995.tb00073.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  3 in total

1.  Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

Authors:  T C Martins; A P Aguas
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease.

Authors:  F Nicoletti; R Di Marco; P Zaccone; G Magro; M Di Mauro; S Grasso; P L Meroni
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

3.  The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients.

Authors:  A Saoudi; B Seddon; D Fowell; D Mason
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.